Literature DB >> 18500026

Survival of eastern oysters Crassostrea virginica from three lines following experimental challenge with bacterial pathogens.

Javier Gómez-León1, Luisa Villamill, Scott A Salger, Rachel H Sallum, Antonio Remacha-Triviño, Dale F Leavitt, Marta Gómez-Chiarri.   

Abstract

Shellfish production is often affected by bacterial pathogens that cause high losses in hatcheries and nurseries. We evaluated the relative survival of larvae and juveniles of 3 Crassostrea virginica oyster lines: (1) GHP, a Rhode Island line; (2) NEHY, a line resistant to dermo and multinucleated sphere X diseases; and (3) FLOWERS, a line resistant to Roseovarius oyster disease, experimental challenge with Vibrio spp. isolates RE22 and RE101, causative agents of bacillary necrosis in Pacific oyster larvae, and the type strain of Roseovarius crassostreae, causative agent of Roseovarius oyster disease. All of the isolates were able to induce significant mortalities in oyster larvae and juveniles. Susceptibility to bacterial challenge in larvae was significantly higher at 25 degrees C than at 20 degrees C. Susceptibility decreased with oyster age; mean survival time ranged from 24 h in oyster larvae to more than 6 wk in juveniles. Significant differences in susceptibility to bacterial challenge were observed between oyster lines; NEHY was the most resistant line overall. Extracellular products (ECPs) from Vibrio sp. RE22 and R. crassostreae, as well as viable bacteria, were toxic to hemocytes from the 3 oyster lines, suggesting that ECPs are involved in pathogenesis and that external and mucosal barriers to infection are major contributors to resistance to bacterial challenge. These protocols will be useful in the elucidation of mechanisms of bacterial pathogenesis and resistance to infection in oysters.

Entities:  

Mesh:

Year:  2008        PMID: 18500026     DOI: 10.3354/dao01902

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  7 in total

1.  Transcriptome of American oysters, Crassostrea virginica, in response to bacterial challenge: insights into potential mechanisms of disease resistance.

Authors:  Ian C McDowell; Chamilani Nikapitiya; Derek Aguiar; Christopher E Lane; Sorin Istrail; Marta Gomez-Chiarri
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

2.  First Report of Vibrio tubiashii Associated with a Massive Larval Mortality Event in a Commercial Hatchery of Scallop Argopecten purpuratus in Chile.

Authors:  Rodrigo Rojas; Claudio D Miranda; Javier Santander; Jaime Romero
Journal:  Front Microbiol       Date:  2016-09-20       Impact factor: 5.640

3.  Draft Genome Sequence of Aliiroseovarius crassostreae CV919-312, the Causative Agent of Roseovarius Oyster Disease (Formerly Juvenile Oyster Disease).

Authors:  Linda Kessner; Edward Spinard; Marta Gomez-Chiarri; David C Rowley; David R Nelson
Journal:  Genome Announc       Date:  2016-03-17

Review 4.  Microbial Diseases of Bivalve Mollusks: Infections, Immunology and Antimicrobial Defense.

Authors:  Carla Zannella; Francesco Mosca; Francesca Mariani; Gianluigi Franci; Veronica Folliero; Marilena Galdiero; Pietro Giorgio Tiscar; Massimiliano Galdiero
Journal:  Mar Drugs       Date:  2017-06-17       Impact factor: 5.118

5.  Complete Genome Sequence of Vibrio coralliilyticus RE22, a Marine Bacterium Pathogenic toward Larval Shellfish.

Authors:  Gary P Richards; Brewster F Kingham; Olga Shevchenko; Michael A Watson; David S Needleman
Journal:  Microbiol Resour Announc       Date:  2018-11-01

Review 6.  New Insights into Pathogenic Vibrios Affecting Bivalves in Hatcheries: Present and Future Prospects.

Authors:  Javier Dubert; Juan L Barja; Jesús L Romalde
Journal:  Front Microbiol       Date:  2017-05-03       Impact factor: 5.640

7.  Comparative genomic analysis of Vibrios yields insights into genes associated with virulence towards C. gigas larvae.

Authors:  Hanna Kehlet-Delgado; Claudia C Häse; Ryan S Mueller
Journal:  BMC Genomics       Date:  2020-08-31       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.